12 天前 - … widely adopted in the field for their capacity to process and learn from large amounts
of image data. In this section, we review the most notable techniques and methodologies …

37 天前 - … This review paper aims to provide comprehensive insights on disease pathogenesis,
FDA-approved treatment, … along with an update on drugs in different clinical phases. The …

44 天前 - … clinical trials to make Stem Cell therapy accessible for AD patients. In this review,
we aim to discuss the AD pathophysiology and varied stem cell types and their application. …

48 天前 - … mild cognitive impairment to severe dementia. In this review, we aimed to discuss
the epidemiological aspects, pathophysiological mechanisms, role of neuroimaging, impact of …

65 天前 - … , Multiple sclerosis (MS), and Parkinson's diseases. In Alzheimer's disease, active
MPO is … Therefore, targeting MPO may be a potential treatment and prevention strategy for …

76 天前 - … This review discusses the current understanding of AD pathogenesis, advances in
diagnostic biomarkers, the latest updates of clinical trials, and emerging technologies for AD …

97 天前 - … pathways in AD pathogenesis. Additionally, we report an update on the potential …
neuroinflammation in AD treatment. Dysregulated activation of microglial receptors and …

98 天前 - … This narrative review aims to assess the risk of amyloid pathology accumulation
and the risk of neurocognitive disorders in patients treated with long-term sacubitril/valsartan, a …

106 天前 - … Our literature review spans from 1957 to 2022, capturing research and trends in
the field over six decades. This review article is an update not only on the recent advances in …

111 天前 - … disease progression and improving clinical outcomes. This review underscores
the critical need for updated … therapies and enhance disease management. Advocating for …